These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
581 related articles for article (PubMed ID: 2804968)
21. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma. Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474 [TBL] [Abstract][Full Text] [Related]
22. Overexpression of glutathione S-transferase and elevation of thiol pools in a multidrug-resistant human colon cancer cell line. Chao CC; Huang YT; Ma CM; Chou WY; Lin-Chao S Mol Pharmacol; 1992 Jan; 41(1):69-75. PubMed ID: 1346333 [TBL] [Abstract][Full Text] [Related]
23. [Mechanisms of resistance to melphalan in leukemia cell line and reversal by interferon alpha]. Qian Q; Yan W; Yang CZ Zhonghua Yi Xue Za Zhi; 1996 Jul; 76(7):485-9. PubMed ID: 9275494 [TBL] [Abstract][Full Text] [Related]
24. Lonidamine as a modulator of alkylating agent activity in vitro and in vivo. Teicher BA; Herman TS; Holden SA; Epelbaum R; Liu SD; Frei E Cancer Res; 1991 Feb; 51(3):780-4. PubMed ID: 1988117 [TBL] [Abstract][Full Text] [Related]
25. Hepsulfam sensitivity in human breast cancer cell lines: the role of glutathione and glutathione S-transferase in resistance. Armstrong DK; Gordon GB; Hilton J; Streeper RT; Colvin OM; Davidson NE Cancer Res; 1992 Mar; 52(6):1416-21. PubMed ID: 1540950 [TBL] [Abstract][Full Text] [Related]
26. Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard. Evans CG; Bodell WJ; Tokuda K; Doane-Setzer P; Smith MT Cancer Res; 1987 May; 47(10):2525-30. PubMed ID: 2882834 [TBL] [Abstract][Full Text] [Related]
27. Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. Behrens BC; Hamilton TC; Masuda H; Grotzinger KR; Whang-Peng J; Louie KG; Knutsen T; McKoy WM; Young RC; Ozols RF Cancer Res; 1987 Jan; 47(2):414-8. PubMed ID: 3539322 [TBL] [Abstract][Full Text] [Related]
28. Characterization of L5178Y murine lymphoblasts resistant to quinone antitumor agents. Begleiter A; Leith MK; McClarty G; Beenken S; Goldenberg GJ; Wright JA Cancer Res; 1988 Apr; 48(7):1727-35. PubMed ID: 3127038 [TBL] [Abstract][Full Text] [Related]
29. Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin. Kasahara K; Fujiwara Y; Nishio K; Ohmori T; Sugimoto Y; Komiya K; Matsuda T; Saijo N Cancer Res; 1991 Jun; 51(12):3237-42. PubMed ID: 1645616 [TBL] [Abstract][Full Text] [Related]
30. Elevated DNA polymerase alpha, DNA polymerase beta, and DNA topoisomerase II in a melphalan-resistant rhabdomyosarcoma xenograft that is cross-resistant to nitrosoureas and topotecan. Friedman HS; Dolan ME; Kaufmann SH; Colvin OM; Griffith OW; Moschel RC; Schold SC; Bigner DD; Ali-Osman F Cancer Res; 1994 Jul; 54(13):3487-93. PubMed ID: 8012971 [TBL] [Abstract][Full Text] [Related]
32. [The expression of GST pi mRNA in the P388/ADR and L1210/DDP resistant lines examined by synthetic probe]. Liu YB Zhonghua Zhong Liu Za Zhi; 1993 Jul; 15(4):264-7. PubMed ID: 8174463 [TBL] [Abstract][Full Text] [Related]
33. Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II). Teicher BA; Holden SA; Kelley MJ; Shea TC; Cucchi CA; Rosowsky A; Henner WD; Frei E Cancer Res; 1987 Jan; 47(2):388-93. PubMed ID: 3539321 [TBL] [Abstract][Full Text] [Related]
34. Alkylator resistance in human B lymphoid cell lines: (1). Melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line (WIL2) and in the melphalan-resistant B-CLL cell line (WSU-CLL). Pu Q; Bianchi P; Bezwoda WR Anticancer Res; 2000; 20(4):2561-8. PubMed ID: 10953327 [TBL] [Abstract][Full Text] [Related]
35. Detection of DNA damage in transcriptionally active genes by RT-PCR and assessment of repair of cisplatin-induced damage in the glutathione S-transferase-pi gene in human glioblastoma cells. Brandt TY; Ali-Osman F Toxicol Appl Pharmacol; 1997 Mar; 143(1):22-9. PubMed ID: 9073588 [TBL] [Abstract][Full Text] [Related]
36. Increased expression of DNA topoisomerase I gene and collateral sensitivity to camptothecin in human cisplatin-resistant bladder cancer cells. Kotoh S; Naito S; Yokomizo A; Kumazawa J; Asakuno K; Kohno K; Kuwano M Cancer Res; 1994 Jun; 54(12):3248-52. PubMed ID: 8205547 [TBL] [Abstract][Full Text] [Related]
37. Characteristics of the glutathione/glutathione-S-transferase detoxification system in melphalan resistant human prostate cancer cells. Ripple M; Mulcahy RT; Wilding G J Urol; 1993 Jul; 150(1):209-14. PubMed ID: 8510259 [TBL] [Abstract][Full Text] [Related]
38. Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion. Green JA; Vistica DT; Young RC; Hamilton TC; Rogan AM; Ozols RF Cancer Res; 1984 Nov; 44(11):5427-31. PubMed ID: 6488194 [TBL] [Abstract][Full Text] [Related]
39. Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous germ cell line. Kelland LR; Mistry P; Abel G; Freidlos F; Loh SY; Roberts JJ; Harrap KR Cancer Res; 1992 Apr; 52(7):1710-6. PubMed ID: 1312897 [TBL] [Abstract][Full Text] [Related]
40. cis-diamminedichloroplatinum(ii) resistance in vitro and in vivo in human embryonal carcinoma cells. Timmer-Bosscha H; Timmer A; Meijer C; de Vries EG; de Jong B; Oosterhuis JW; Mulder NH Cancer Res; 1993 Dec; 53(23):5707-13. PubMed ID: 8242627 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]